News on : ANDA

Dr. Reddy’s Announces the Launch of Decitabine for Injection

Hyderabad, July 12 (INN): Dr. Reddy’s Laboratories announced today that it has launched Decitabine for Injection

Dr. Reddy’s Announces the Launch of Lamotrigine Extended-Release Tablets

Hyderabad, June 26 (INN): Dr. Reddy’s Laboratories announced today that it has launched Lamotrigine Extended-Release Tablets (25 mg, 50 mg, 100 mg, 200 mg, 300 mg)

Dr Reddy’s Sued for ‘Infringing’ Thyroid Injection Patent

Hyderabad, June 19 (INN): US-based drug maker AbbVie Inc, the spun-off entity of Abbott, has dragged Dr Reddy’s Lab to court for allegedly infringing the former’s patented drug Zemplar on six counts concerning three patents. “DRL committed an act of infringement by filing an ANDA (Abbreviated New Drug Application) with a Paragraph IV Certification that […]